Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gain of 1q21 is an unfavorable genetic prognostic factor for multiple myeloma patients treated with high-dose chemotherapy.
Nemec P, Zemanova Z, Greslikova H, Michalova K, Filkova H, Tajtlova J, Kralova D, Kupska R, Smetana J, Krejci M, Pour L, Zahradova L, Sandecka V, Adam Z, Buchler T, Spicka I, Gregora E, Kuglik P, Hajek R. Nemec P, et al. Among authors: buchler t. Biol Blood Marrow Transplant. 2010 Apr;16(4):548-54. doi: 10.1016/j.bbmt.2009.11.025. Epub 2010 Jan 18. Biol Blood Marrow Transplant. 2010. PMID: 20005965 Free article. Clinical Trial.
[Quality of life and tolerance of maintenance therapy in patients with multiple myeloma].
Adam Z, Pour L, Svobodník A, Scudla V, Salajka F, Vytrasová M, Bacovský J, Schützová M, Koza V, Sumná E, Franková H, Lehanka F, Gumulec J, Stavarová Y, Cahová S, Vránová M, Dostálová V, Kessler P, Walterová L, Meluzínová I, Seifertová N, Sláma O, Büchler T, Krejcí M, Bencíková V, Nykodýmová V, Dusek L, Hájek R; Czech Myeloma Group. Adam Z, et al. Among authors: buchler t. Vnitr Lek. 2002 Mar;48(3):216-29. Vnitr Lek. 2002. PMID: 11968583 Clinical Trial. Czech.
Interleukin-2 activation of haematopoietic stem cells.
Hájek R, Korístek Z, Vinklárková J, Janovská E, Klabusay M, Doubek M, Dvoráková D, Bourková L, Dusek L, Büchler T, Adler J, Adam Z, Penka M, Mayer J, Vorlícek J. Hájek R, et al. Among authors: buchler t. Acta Med Austriaca. 2002;29(2):61-7. doi: 10.1046/j.1563-2571.2002.02005.x. Acta Med Austriaca. 2002. PMID: 12050948
Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration.
Hájek R, Zácková D, Büchler T, Penka M, Krahulcová E, Korístek Z, Vinklárková J, Adler J, Janovská E, Indrák K, Faber E, Doubek M, Klabusay M, Oltová A, Kuglík P, Bourková L, Dusek L, Mareschová I, Mayer J, Vorlícek J. Hájek R, et al. Among authors: buchler t. Med Oncol. 2003;20(1):69-76. doi: 10.1385/mo:20:1:69. Med Oncol. 2003. PMID: 12665687 Clinical Trial.
Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group.
Krivanová A, Hájek R, Krejcí M, Scudla V, Indrák K, Bacovský J, Büchler T, Svobodník A, Adam Z, Mayer J, Vorlícek J; Czech Myeloma Group. Krivanová A, et al. Among authors: buchler t. Onkologie. 2004 Jun;27(3):275-9. doi: 10.1159/000077977. Onkologie. 2004. PMID: 15249717 Clinical Trial.
T lymphocyte therapy of cancer.
Michálek J, Büchler T, Hájek R. Michálek J, et al. Among authors: buchler t. Physiol Res. 2004;53(5):463-9. Physiol Res. 2004. PMID: 15479123 Free article. Review.
231 results